The nasal spray vaccine, known as FluMist, has been on the market since 2003 and is as effective as the traditional flu shot, according to the CDC. What sets this approval apart is that it can now be administered outside of healthcare settings, although a prescription is still required.
Director of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, MD, PhD, stated, “Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine with greater convenience, flexibility, and accessibility.”
Related Stories
To receive the at-home vaccine, patients must obtain a prescription from their doctor through an online pharmacy. The pharmacy will conduct a screening to ensure no adverse reactions are present before shipping the spray. Detailed administration instructions, storage, and disposal information are included with the spray.
Side effects of FluMist are similar to traditional flu shots, including runny nose, congestion, sore throat, and a low-grade fever in children. Most Medicaid, Medicare, and private insurance plans cover flu vaccines at no cost, but coverage for at-home administration is not confirmed. The current out-of-pocket cost for a dose is between $35 and $45, with a tentative fall launch for the self-administered vaccine.
For now, patients still need to visit healthcare providers or pharmacies for their flu shots or FluMist administration. It’s recommended to get vaccinated now, along with your annual COVID booster shot.
